Vanguard Fiduciary Trust
ADMA icon

Vanguard Fiduciary Trust’s ADMA Biologics ADMA Stock Holding History

Vanguard Fiduciary Trust’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.8M Buy
1,654,613
+17,054
+1% +$155K ﹤0.01% 1633
2026
Q1 		$14.8M Buy
+1,637,559
New +$25.8M ﹤0.01% 1499

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Fiduciary Trust's ADMA Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its ADMA Biologics (ADMA) stake by 1% in Q2 2026, buying an estimated $155K and bringing the position to 1,654,613 shares worth $13.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1633.

Vanguard Fiduciary Trust first reported a position in ADMA in Q1 2026 and has held it in 2 quarters since. The position peaked at $14.8M in Q1 2026. 320 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Vanguard Fiduciary Trust held 1,654,613 shares of ADMA Biologics worth $13.8M as of Q2 2026.
  • Vanguard Fiduciary Trust bought 17,054 ADMA Biologics shares in Q2 2026, an estimated $155K.
  • ADMA Biologics made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #1633 holding.
  • Vanguard Fiduciary Trust first reported a position in ADMA Biologics in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's ADMA Biologics position peaked at $14.8M in Q1 2026.
  • 320 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.